HUMAN GENOME SCIENCES INC
S-8, EX-5.1, 2000-08-30
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: HUMAN GENOME SCIENCES INC, S-8, 2000-08-30
Next: HUMAN GENOME SCIENCES INC, S-8, EX-23.2, 2000-08-30





                                   EXHIBIT 5.1

----------------
PIPER
MARBURY
RUDNICK
& WOLFE   LLP
----------------

6225 Smith Avenue
Baltimore, Maryland 21209-3600
www.piperrudnick.com

PHONE    (410) 580-3000
FAX      (410) 580-3001

                                 August 30, 2000

Human Genome Sciences, Inc.
9410 Key West Avenue
Rockville, Maryland 218050-3338

Ladies and Gentlemen:

         We have acted as counsel to Human  Genome  Sciences,  Inc.,  a Delaware
Corporation (the "Company"),  in connection with the preparation and filing with
the Securities and Exchange  Commission of a registration  statement on Form S-8
(the "Registration  Statement")  registering 250,000 shares of Common Stock, par
value $.01 per share (the "Common  Stock"),  issuable  pursuant to subscriptions
under the  Company's  Employee  Stock  Purchase  Plan (the "Plan  Shares"),  and
13,804,454  shares of Common  Stock  issuable  pursuant to the exercise of stock
options  granted under the Company's  2000 Stock  Incentive Plan (such plans are
collectively  referred to herein as the "Plans," and such shares  issuable under
the Plans are collectively referred to herein as the "Plan Shares").

         We have  examined  copies  of the  Company's  Restated  Certificate  of
Incorporation  (as amended),  By-Laws (as amended),  the Plans,  all resolutions
adopted by the  Company's  Board of  Directors  relating  to the above and other
records  and  documents  that we have deemed  necessary  for the purpose of this
opinion.  We have also  examined  such other  documents,  papers,  statutes  and
authorities as we have deemed necessary to form a basis for this opinion. In our
examination,  we  have  assumed  the  genuineness  of  all  signatures  and  the
conformity  to original  documents of all copies  submitted to us. As to various
questions of fact  material to this opinion,  we have relied on  statements  and
certificates of officers and representatives of the Company and others.

         Based  upon the  foregoing,  we are of the  opinion  that  Plan  Shares
issuable  under the Plans have been duly  authorized  and will be (when  issued,
sold and delivered as authorized) validly issued, fully paid and non-assessable.

         The opinions  set forth  herein are limited to matters  governed by the
laws of the State of  Delaware  and the  Federal  Laws of the  United  States of
America, and we express no opinion as to any other laws.

         We hereby  consent to the filing of this  opinion as Exhibit 5.1 to the
Registration Statement.

                                   Very truly yours,

                                    /s/ PIPER MARBURY RUDNICK & WOLFE LLP

<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission